14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.95 $2.61 Wednesday, 24th Apr 2024 CHRS stock ended at $2.02. This is 7.34% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 9.41% from a day low at $2.02 to a day high of $2.21.
90 days $1.93 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Jun 07, 2021 $13.30 $14.07 $13.08 $13.71 1 083 920
Jun 04, 2021 $14.00 $14.20 $13.21 $13.27 962 297
Jun 03, 2021 $13.15 $13.28 $12.91 $13.04 749 513
Jun 02, 2021 $13.47 $13.55 $12.98 $13.15 851 501
Jun 01, 2021 $13.17 $13.51 $13.09 $13.47 1 071 733
May 28, 2021 $13.25 $13.48 $13.07 $13.16 557 847
May 27, 2021 $13.30 $13.32 $13.01 $13.17 795 148
May 26, 2021 $13.04 $13.27 $12.90 $13.14 713 740
May 25, 2021 $13.27 $13.32 $12.94 $12.95 709 008
May 24, 2021 $13.57 $13.57 $13.15 $13.19 801 369
May 21, 2021 $13.79 $13.79 $13.48 $13.48 767 560
May 20, 2021 $13.58 $13.83 $13.43 $13.68 702 741
May 19, 2021 $13.70 $13.80 $13.41 $13.62 1 653 379
May 18, 2021 $14.15 $14.38 $13.81 $13.84 659 079
May 17, 2021 $14.85 $14.90 $14.07 $14.14 1 332 921
May 14, 2021 $13.87 $15.20 $13.80 $15.13 1 042 830
May 13, 2021 $13.94 $14.14 $13.66 $13.89 828 509
May 12, 2021 $14.00 $14.28 $13.83 $13.85 869 921
May 11, 2021 $14.02 $14.53 $13.94 $14.08 639 338
May 10, 2021 $14.30 $14.69 $14.10 $14.28 1 012 237
May 07, 2021 $14.52 $14.88 $14.00 $14.32 870 545
May 06, 2021 $14.41 $14.67 $14.01 $14.50 984 752
May 05, 2021 $14.95 $14.95 $14.42 $14.55 579 915
May 04, 2021 $15.09 $15.14 $14.67 $14.79 765 921
May 03, 2021 $14.92 $15.47 $14.75 $15.24 848 364
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT